Termination of second-trimester intrauterine fetal demise with prostaglandins.
D000019:Abortifacient Agents; D000028:Abortion, Induced; D001695:Biology; D002584:Cervix Uteri; D004467:Economics; D004703:Endocrine System; D005193:Family Planning Services; D010121:Oxytocin; D010827:Physiology; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; D012098:Reproduction; D012106:Research; D013672:Technology
D000019:Abortifacient Agents; D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; D010121:Oxytocin
Abortifacient Agents; Abortion, Drug Induced; Abortion, Induced; Biology; Cervix; Economic Factors; Endocrine System; Family Planning; Fertility Control, Postconception; Oxytocin; Physiology; Pregnancy; Pregnancy, Second Trimester; Prostaglandins, Synthetic; Prostaglandins--administraction and dosage; Prostaglandins--complications; Prostaglandins--side effects; Reproduction; Research And Development; Technology